Prior authorisation: what the criteria usually require — a second dataset posts 61–75
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Post #59 and I disagree about the size of the effect, not about the direction.
The most useful thing anyone has posted about Prior authorisation in this category was a table of what had been measured and by whom. That is what I would want again.
A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally.
This follows post #62 rather than contradicting it.
Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying it.
A partial answer, offered because a partial answer beats none.
The single most useful preparation is obtaining the actual criteria document rather than working from what somebody was told on the phone.
Where the Prior authorisation reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Speaking only to Prior authorisation as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.
Date every account in this subcategory. Payer criteria change frequently and the archive keeps posts permanently.
Where I part company with post #67, and it is a narrow parting.
The number people quote for Prior authorisation is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on its own.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
That is what I would do. It may not be what is correct.
What does not work: describing how the decision made you feel, however justified. The reviewer is checking criteria and the job is to make them checkable.
Post #71 put the caveat in the right place and I want to underline it.
A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally.
This topic was referenced in
- An appeal that succeeded, with the letter structureAccess › Insurance & coverage · 16 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
An appeal that failed, and what I would do differently
An appeal that failed, and what I would do differently Writing it up because I had to work it out twice and would rather nobody else did. Asking about appeal directly, because I have read four threads on it…
|
+4 | 8 | 125 | 12mo |
|
Revisiting: Reading a denial letter as a specification for your appeal
Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. Asking about Reading a denial letter on behalf of…
|
+125 | 138 | 9.4k | 10mo |
|
Coverage for the indication versus for the drug
Coverage for the indication versus for the drug — setting out what I have, and where I think it stops being reliable. The question about coverage that I actually want answered is the second one below. The…
|
+70 | 79 | 18k | 14mo |
|
Follow-up: Prior authorisation: what the criteria usually require
Prior authorisation: what the criteria usually require — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about Prior authorisation.…
|
+95 | 100 | 9.1k | 10h |
|
[2026 update] An appeal that failed, and what I would do differently
Posting this under the heading it deserves: An appeal that failed, and what I would do differently Everything below is what sits behind that. Asking about appeal directly, because I have read four threads on…
|
+152 | 159 | 2.5k | 13mo |
Related topics — sharing the tags prior authorisation, insurance, formulary
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…
|
+46 | 50 | 7.9k | 5mo |
|
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. Official shortage notices — I have the observation and I do not trust my…
|
+85 | 92 | 5.5k | 11mo |
|
External review after an internal denial
External review after an internal denial Writing it up because I had to work it out twice and would rather nobody else did. Proposing that external review deserves a maintained page rather than a recurring…
|
2 | 18k | 1mo | |
|
What to bring: records that a clinician can actually use
Asking directly, because I could not find a straight answer: What to bring: records that a clinician can actually use A question about how to describe something to a clinician rather than about the thing…
|
+15 | 19 | 6.4k | 1d |
|
Reading a denial letter as a specification for your appeal
Reading a denial letter as a specification for your appeal Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here about reading a…
|
3 | 30k | 12mo |